We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Type
- ARTG (88)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (11)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Prescription medicine evaluation (2)
- Cancellation or suspension (1)
Sponsor content
155 result(s) found, displaying 71 to 80
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
Section 14, TGO91 consentProduct(s) approved for Supply with noncompliant labelling.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AFLURIA QUAD - Inactivated Quadrivalent Influenza vaccine (split virion), 60 mcg HA, Suspension for injection, pre-filled syringe needle-free.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELTASSA patiromer (as sorbitex calcium) 25.2 g powder for oral suspension sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELTASSA patiromer (as sorbitex calcium) 8.4 g powder for oral suspension sachet.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELTASSA patiromer (as sorbitex calcium)16.8 g powder for oral suspension sachet.
-
Prescription medicine registrationActive ingredients: olopatadine hydrochloride; mometasone furoate monohydrate.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Influenza virus haemagglutinin
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Bulk Quadrivalent Influenza Vaccine (split virion, inactivated) Thiomersal containing.
-
Prescription medicine registrationActive ingredients: inactivated quadrivalent influenza vaccine.